Medlive’s HK$4.22 Billion Hong Kong IPO and Rule 144A/Regulation S Offering

Simpson Thacher and Maples and Calder advised Medlive Technology Co. on the deal. King & Wood Mallesons acted as the PRC legal counsel for the sponsors,…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Alejandro Girola

This content is for Standard 1 Year members only.
Login Join Now